53
Sequential testing identifies biomarkers and antibodies aiding in the diagnosis and management of membranous nephropathy.

The Primary Membranous Nephropathy Diagnostic Cascade involves a series of serological tests on serum to diagnose membranous nephropathy. It includes detecting autoantibodies like anti-PLA2R and anti-THSD7A, assessing kidney function, and identifying underlying causes. This diagnostic approach helps confirm the condition, differentiate it from other kidney diseases, guide treatment decisions, and monitor disease progression and response to therapy. It is crucial in managing patients with membranous nephropathy to optimize renal health and prevent complications like kidney failure.
Differentiating between primary and secondary membranous nephropathy through an algorithmic method.
Observing patients with membranous nephropathy with minimal antibody levels.
Testing for anti-phospholipase A2 receptor antibodies.
EURO: Enzyme-Linked Immunosorbent Assay (ELISA)
PLA2I, THSD7: Indirect Immunofluorescence Assay (IFA)
TBC
Prim Membranous Nephropathy Diag, S
Trust PULSE CLINIC to take care of your health like other 45000 people from over 130 countries. We provide discreet professional service with high privacy. Here to help, not to judge.
Serum
TBC
Supplies: Sarstedt Aliquot Tube, 5 mL
Collection Container/Tube:
Preferred: Serum gel
Acceptable: Red top
Submission Container/Tube: Plastic vial
Specimen Volume: 1 mL
Collection Instructions: Centrifuge and aliquot serum into a plastic vial.
1 mL
Trust PULSE CLINIC to take care of your health like other 45000 people from over 130 countries. We provide discreet professional service with high privacy. Here to help, not to judge.